TC BioPharm Investors
TC BioPharm developing safer, cheaper, consistent and durable CAR-T drugs for hematological and solid tumors.
Headquarters:
Holytown, North Lanarkshire, United Kingdom
Industry:
Advanced and Next Generation Therapies (Various)
Number Of Exists:
N/A
Investor Type:
Healthcare Company
Technology:
Advanced Longevity (R&D)
Employee Number:
11-50
Founded Date:
2013









